These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7876462)

  • 1. The effect of interferon on activated peripheral blood T lymphocytes in patients with chronic active hepatitis B.
    Raptopoulou-Gigi M; Orphanou-Koumerkeridou H
    Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):577-88. PubMed ID: 7876462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interferon is useful in the treatment of chronic hepatitis B].
    Vuoristo M
    Duodecim; 1991; 107(13):1087-90. PubMed ID: 1365335
    [No Abstract]   [Full Text] [Related]  

  • 3. alpha-Interferon therapy in patients with chronic active hepatitis B: immunological profile.
    Raptopoulou-Gigi M; Orphanou-Koumerkeridou H; Lagra F; Vacolas J; Goulis G; Vrettou H
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):330-4. PubMed ID: 1669591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the treatment of chronic active hepatitis (HBsAg+) with isoprinosine. II. Immunological studies].
    Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A; Cianciara J; Loch T; Babiuch L
    Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):347-51. PubMed ID: 1700402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha-interferon and prednisone on serum-soluble interleukin-2 receptor (sIL-2R) in chronic hepatitis B infection.
    Leung NW; Leung JC; Tam JS; Lau JT; Lai KN
    Am J Gastroenterol; 1992 Jan; 87(1):113-7. PubMed ID: 1728107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic hepatitis treated with alpha-interferon].
    Michael M
    Orv Hetil; 1992 Jul; 133 Suppl 1():63-5. PubMed ID: 1630805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
    Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
    Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case from practice (312). Chronic active hepatitis B--nonresponder to interferon therapy].
    Stoll A
    Praxis (Bern 1994); 1994 Nov; 83(48):1359-60. PubMed ID: 7801008
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of dimephosphon on the clinico-immunological indicators in children with chronic hepatitis].
    Gorbunova IV; Shabunina EI; Maianskaia IV; Studentsova IA
    Pediatriia; 1991; (10):111-2. PubMed ID: 1787992
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study.
    Trépo C; Rougier P; Bizollon T; Poupon R; Zarski JP; Quinton A; Miguet JP; Causse X; Chossegros P; Chevallier M
    J Hepatol; 1991; 13 Suppl 1():S3. PubMed ID: 1720439
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vidarabine-interferon combination in patients with chronic viral hepatitis B of mutant form. Efficiency and tolerability during a pilot study].
    Durand M; Bost F; Maynard M; Baud M; Cohard M; Zarski JP
    Presse Med; 1996 Mar; 25(9):459. PubMed ID: 8685199
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interferon therapy of chronic hepatitis B in children].
    Pilette C; Calès P
    Gastroenterol Clin Biol; 1995 Jan; 19(1):139-42. PubMed ID: 7720983
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive indicators for the therapeutic effect of OK-432 in patients with chronic active type B hepatitis.
    Nishimura K; Ishizaka S; Tsujii T
    Biotherapy; 1992; 4(4):299-306. PubMed ID: 1622743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in T cell subsets and the expression of receptors of transferrin and interleukin-2 in chronic active hepatitis].
    Tang W
    Zhonghua Yi Xue Za Zhi; 1992 Feb; 72(2):91-3, 128. PubMed ID: 1327441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic hepatitis B with interferon alfa-2b (Intron A)].
    Cianciara J; Laskus T; Hryniewicz H; Jabłońska J; Loch T
    Przegl Epidemiol; 1991; 45(4):315-20. PubMed ID: 1841409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
    Robson SC; Brice E; van Rensburg C; Kannemeyer J; Hift RJ; Kirsch RE
    S Afr Med J; 1992 Nov; 82(5):317-20. PubMed ID: 1448711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy noncompliance in chronic viral hepatitis--standard therapy, prognostic parameters, treatment strategy].
    Hopf U
    Praxis (Bern 1994); 1997 Jan; 86(4):83-5. PubMed ID: 9064723
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B.
    Kakumu S; Ishikawa T; Wakita T; Yoshioka K; Takayanagi M; Tahara H; Kusakabe A
    Am J Gastroenterol; 1994 Jan; 89(1):92-6. PubMed ID: 8273806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.